Selvaraj Jayaraman

9PUBLICATIONS
18CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Sesamin Suppresses Ovarian Cancer Progression via Modulation of Wnt/β-Catenin and Associated Oncogenic Pathways.

|May 22, 2026
Sesamin Mitigates Gastric Carcinogenesis via Modulation of the PI3K/AKT/mTOR Signaling Pathway in AGS Cells and MNNG-Induced Rats.

|May 21, 2026
Hexavalent Chromium Exposure Disrupts Cardiac Development in Chicken Embryos Through Oxidative Stress and Activation of TGFβ1/COL3A1 Pathway in Chick Embryos.

|Apr 07, 2026
Molecular Insights into Identification of Natural AKT1/mTOR Signaling Inhibitors from Veratrum Viride-Derived Alkaloids for Breast Cancer Treatment: A Comprehensive Analysis Using Network Pharmacology, Molecular Docking, and Molecular Dynamics.

Anu Priya Eswaran, Selvaraj Jayaraman, Sathan Raj Natarajan

|Mar 07, 2026
Mechanistic Exploration of the anticancer activity of Justicia adhatoda Plant Leaf Ethanolic Extract against Colon Cancer Cells: An in silico and in vitro Approach.

Bhuvaneswari Ponnusamy, Ponnulakshmi Rajagopal, Chella Perumal Palanisamy

|Jan 22, 2026
Role of PDGF-BB in Oral Squamous Cell Carcinoma through PI3/AKT/mTOR Pathway: An Integrated Computational and Real-Time PCR-Based Approach.

Georgia Benitha J, Pratibha Ramani, Selvaraj Jayaraman

Pageof 2

Frequent Collaborators

3 joint publications

Vishnu Priya Veeraraghavan

3 joint publications

Ponnulakshmi Rajagopal

2 joint publications

Heera Maheswari Jayaveeran

2 joint publications

Manju Parthiban